A patient-led Roundtable on late, missed and misdiagnosis of heart disease in women
Heart Sisters
SEPTEMBER 15, 2024
“These cardiac care recommendations are patient-centred and targeted towards addressing women’s specific needs and concerns.
Sun.Sep 15, 2024
123 
Cardiometabolic benefits of fenofibrate in heart failure related to obesity and diabetes
Cardiovascular Diabetology
SEPTEMBER 15, 2024
Background Heart failure (HF) is a serious and common condition affecting millions of people worldwide, with obesity being a major cause of metabolic disorders such as diabetes and cardiovascular disease. This study aimed to investigate the effects of fenofibrate, a peroxisome proliferator-activated receptor alpha (PPARα) agonist, on the obese- and diabetes-related cardiomyopathy.
LIBERTY-CUPID Study C Confirms Benefit of Dupilumab in Biologic-Naive CSU
HCPLive
SEPTEMBER 15, 2024
Dupilumab reduced itch and disease activity in patients with uncontrolled CSU, confirming prior findings from the LIBERTY-CUPID program in a phase 3 trial.
Differential roles of eosinophils in cardiovascular disease
Nature Reviews - Cardiology
SEPTEMBER 15, 2024
Nature Reviews Cardiology, Published online: 16 September 2024; doi:10.1038/s41569-024-01071-5 In this Review, Shi and co-workers summarize the available evidence on the role of eosinophils in cardiovascular diseases, highlighting differences between preclinical and clinical findings and placing clinical data in the context of experimental data to discuss potential pathogenic or protective roles of eosinophils in different cardiovascular disease settings.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Microplastics and Cardiovascular Diseases: Importance of Coexisting Environmental Pollutants
Circulation
SEPTEMBER 15, 2024
Circulation, Volume 150, Issue 12 , Page 908-910, September 17, 2024.
Challenging Arrhythmias — MIS-C Case Report (9-16.1-2024) - NOT_YET_FINISHED
Ken Grauer, MD
SEPTEMBER 15, 2024
== Review of ECG Rhythms — MIS-C Case Report ( 9/5 /2024 ): == What follows below are my first impressions of the ECG rhythms sent to me from the Case Report by Dimah Jarmakani et al — of a 12-year old boy with MIS-C ( M ultisystem I nflammatory S yndrome in C hildren ). For full discussion of the case — CLICK HERE — ECG Rhythm Overview: A 12-year-old boy was admitted to our hospital with severe myocardial dysfunction and chaotic rhythm with tachy- and bradycardic arrhythmias.
Sign up to get articles personalized to your interests!
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
More Trending
Internet Source Quality Influences Psoriasis Management
HCPLive
SEPTEMBER 15, 2024
Commercial and government-based sources on Google scored the highest in quality, while medical practices scored the lowest, for information on psoriasis.
A Giant Left Anterior Descending Artery Aneurysm and an Updated Review on Coronary Aneurysms
The American Journal of Cardiology
SEPTEMBER 15, 2024
Publication date: Available online 14 September 2024 Source: The American Journal of Cardiology Author(s): Aldo E Rafael-Yarihuaman, Jerry Wang, Cristhian Guevara, Avantika Banerjee, Robert C. Stoler, Julio E.
Clinical Quiz: Lifestyle and Comorbidities from 2020 ACR Gout Guidelines
HCPLive
SEPTEMBER 15, 2024
This clinical quiz, our third in a series of 4, focuses on recommendations for lifestyle and comorbidity management from the 2020 ACR guidelines.
Women and Heart Health: Unique Considerations and Risks
MIBHS
SEPTEMBER 15, 2024
Heart disease is often perceived as a predominantly male issue, but the reality tells a different story. It’s the leading cause of death for women, claiming more lives each year than all forms of cancer combined. Despite its prevalence, many women are unaware of the unique risks and symptoms they face, often underestimating the threat it poses. This blog post aims to shed light on the unique considerations and risks associated with heart health in women, empowering them with the knowledge to tak
Highlights From the Circulation Family of Journals
Circulation
SEPTEMBER 15, 2024
Circulation, Volume 150, Issue 12 , Page 966-970, September 17, 2024.
What is New in the ESC Hypertension Guideline?
Hypertension Journal
SEPTEMBER 15, 2024
Hypertension, Ahead of Print. Blood pressure guidelines serve as a beacon of best practice for the diagnosis and management of hypertension. The many cultural and societal differences in hypertension risk factors and management patterns across geographic regions support the need for geographically distinct international guidelines. In 2018, the European Society of Cardiology (ESC) and European Society of Hypertension (ESH) released a joint guideline for the management of hypertension.1 This guid
Correction to: Phosphorylation-Regulated Dynamic Phase Separation of HIP-55 Protects Against Heart Failure
Circulation
SEPTEMBER 15, 2024
Circulation, Volume 150, Issue 12 , Page e268-e268, September 17, 2024.
To Harmonize or to Hinder. Do We Need Two Sets of European Guidelines in 2024?
Hypertension Journal
SEPTEMBER 15, 2024
Hypertension, Ahead of Print. Hypertension control remains a significant challenge globally.1 Even in Europe, a region that has produced some of the best science on managing hypertension, the control rates of hypertension is poor, ranging between ~20% and 40% for most countries.2 If this was a simple issue to solve, one could ask – what do we need to ensure that the 60% to 80% of people with hypertension who are at high risk of a stroke, heart attack and other consequences, are not left behind?
Correction to: 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Circulation
SEPTEMBER 15, 2024
Circulation, Volume 150, Issue 12 , Page e267-e267, September 17, 2024.
Interactions of contact force, impedance and power during repeat atrial arrhythmia ablation after previous atrial fibrillation ablation
HeartRhythm
SEPTEMBER 15, 2024
Acutely effective repeat radiofrequency catheter ablation (RFCA) after previous atrial fibrillation ablation depends on several parameters including local impedance (LI), contact force (CF) and power.
Letter by Maron et al Regarding Article, “Sudden Cardiac Death in National Collegiate Athletic Association Athletes”
Circulation
SEPTEMBER 15, 2024
Circulation, Volume 150, Issue 12 , Page e255-e256, September 17, 2024.
Sex inequalities in cardiovascular risk factors and their management in primary prevention in adults living with type 1 diabetes in Germany and France: findings from DPV and SFDT1
Cardiovascular Diabetology
SEPTEMBER 15, 2024
To evaluate whether cardiovascular risk factors and their management differ in primary prevention between adult males and females with type 1 diabetes (T1D) in two European countries in 2020–2022 and sex inequ.
Arterial Thrombosis: Present and Future
Circulation
SEPTEMBER 15, 2024
Circulation, Volume 150, Issue 12 , Page 905-907, September 17, 2024.
Let's personalize your content